Send Message
Home ProductsSmall Volume Injection

Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Certification
China ANHUI BBCA PHARMACEUTICAL CO.,LTD certification
China ANHUI BBCA PHARMACEUTICAL CO.,LTD certification
Customer Reviews
Dear Sunny, Thank you so much for your company for quick shipment of the goods,we have caught up with the market. Best Rgeards, Erci Mohammad

—— Eric Mohammad

Dear Sunny, The quality of Paracetamol is very good,our customer is very satisfied.Thank you so much! Best Regards, Jean Green

—— Jean Green

I'm Online Chat Now

Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid
Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Large Image :  Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Product Details:
Place of Origin: China
Brand Name: BBCA
Certification: GMP
Model Number: BBCA18011511
Payment & Shipping Terms:
Price: Negotiated
Packaging Details: 40 Glass Bottles/Carton
Delivery Time: 25 DAYS AFTER PAYMENT
Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram

Small Volume Injection Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Description
Place Of Origin: China (Mainland) Brand Name: BBCA
Other Names: Pharmaceutical Transfusion GMP Certified Ciprofloxacin Lactate Injection Grade: Medicine Grade
Dosage Form: Injection
High Light:

metronidazole injection

,

glucose injection

Pharmaceutical Ciprofloxacin Lactate Injection Nearly Colorless Liquid

Specifications

1. Product Name: Pharmaceutical Transfusion GMP Certified Ciprofloxacin Lactate Injection

 

 

2. Component: The main ingredients of this product are as follows: ciprofloxacin lactate.

 

 

3. Appearance: This product is colorless or nearly colorless transparent liquid.

 

 

4. Indications:

 

Used for sensitive bacteria caused by:
1. Urinary reproductive system infection, including simple and complicated urinary tract infection, bacterial prostatitis, bacteria neisseria gonorrhea urethritis and cervicitis (including enzyme production strains caused by).
2. Respiratory tract infections, including sensitive acute bronchial infection caused by gram-negative bacilli and lung infection.
3. Gastrointestinal tract infection, by shigella, salmonella and e. coli to produce enterotoxin, moisture, deputy hemolytic bacterium vibrio, etc.
4. Typhoid.
5. Bone and joint infections.
6. Skin soft tissue infection.
7. Sepsis and systemic infection.

5. Specifications: 100ml: 0.2g of ciprofloxacin

 

6. Usage and Dosage: This product is for intravenous drip.For any patient, the dose should be according to the degree and nature of infection, the sensitivity of the pathogen, patients with the body's resistance, and liver function to determine.
Adults generally use a 0.1 0.2 g, intravenous drip once every 12 hours, every 0.2 g drip time in more than 30 minutes at least, severe infection or pseudomonas aeruginosa infection can increase the dose to a 0.4 g, 2 to 3 times a day.
Treatment depends on the degree of infection.In treatment for 7 to 14 days, usually in infection should also continue to use at least 2 days after symptoms disappear.
1. Urinary tract infection, acute simple urinary tract infection (5-7;Complexity urinary tract infection (7-14;
2. Pneumonia and skin soft tissue infection: 7-14;
3. Intestinal infection: 5-7;
4. The bone and joint infections: 4 to 6 weeks or longer.
5. Typhoid fever: 10-14.

 

7. Contraindications: This product and any fluoroquinolone drugs patients with a history of allergies are prohibited.

 

8. Pharmacological mechanisms: Intravenous drip annotated product within 60 minutes after 200 mg and 400 mg, about 1 hour after peak of blood drug concentration, were 2.1 mg/L and 4.6 mg/L.Can be widely distributed to various body fluids (including cerebrospinal fluid) and organizations, organizations often more than the concentration of blood drug concentration.Protein binding rate of about 20% ~ 40%.After intravenous administration, 50% ~ 70% of the drugs to prototype from the urine, about 14% of the bile and its droppings.24 hours discharge dosage of more than 90%.Elimination half-life of 5-6 hours, decreased renal function can be extended.

 

9. Storage: Protect from light, airtight preservation.

 

 

10. Package: 100ml/glass bottle; 40 glass bottles/carton

 

 

 

Contact Details
ANHUI BBCA PHARMACEUTICAL CO.,LTD

Contact Person: Mr. Eric

Tel: +86-551-64846195

Fax: 86-551-64846082

Send your inquiry directly to us (0 / 3000)